Biogen (BIIB) Restructuring Costs (2010 - 2026)
Biogen (BIIB) posted Restructuring Costs of $66.5 million for Q3 2026, up 798.6% from $7.4 million a year earlier but down 59.8% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Restructuring Costs (2010 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Restructuring Costs at Biogen was $246.4 million, up 420.9% year-over-year; for FY2025, it was $48.6 million, up 60.9% from FY2024.
- Annual Restructuring Costs shows a three-year compound annual growth rate of -28.2% (FY2022 to FY2025).
- In prior years, Biogen's Restructuring Costs was $30.2 million in FY2024 (-86.2%), $218.8 million in FY2023 (+66.9%) and $131.1 million in FY2022.
- Quarterly Restructuring Costs has run from a low of -$700,000 in Q2 2025 to a high of $165.4 million in Q2 2026 over five years.
- On a year-over-year basis, Restructuring Costs increased in four of the last six quarters, with growth averaging 144.5%.
- The strongest year-over-year quarter for Restructuring Costs in the past five years was Q3 2026, with growth of 798.6%; the weakest was Q4 2024, with a decline of 94.6%.
- According to Business Quant data, Restructuring Costs for the three prior quarters was $165.4 million (Q2 2026), $7.9 million (Q1 2026) and $6.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 66.50 Mn |
| Jun 30, 2026 | 165.40 Mn |
| Mar 31, 2026 | 7.90 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | -700,000.00 |
| Mar 31, 2025 | 35.30 Mn |
| Dec 31, 2024 | 5.30 Mn |
| Sep 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | 11.50 Mn |
| Dec 31, 2023 | 98.80 Mn |
| Sep 30, 2023 | 76.00 Mn |
| Jun 30, 2023 | 34.40 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 15.40 Mn |
| Jun 30, 2022 | 70.60 Mn |
| Mar 31, 2022 | 38.10 Mn |
| Sep 30, 2019 | 300,000.00 |
API Access
Biogen Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();